These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4098112)

  • 41. [Use of polyatomic alcohols in gastroenterology (review of literature and our own data)].
    Rafes IuI; Ardelian VN
    Ter Arkh; 1970 Jun; 42(6):17-21. PubMed ID: 5492072
    [No Abstract]   [Full Text] [Related]  

  • 42. [Aluminum and magnesium pentasilicates associated with pectin and sorbitol in gastrointestinal disorders observed in children during treatment by tuberculostatics].
    Gerbeaux J; Baculard A; Hanoteau J
    Actual Hepatogastroenterol (Paris); 1968; 4(1):B23-4. PubMed ID: 5721702
    [No Abstract]   [Full Text] [Related]  

  • 43. [Polivinyl polypyrrolidone (Bolinan 40) in digestive pathology: its behavior with respect to covering the digestive mucosa].
    Jeanpierre RE; Dornier R; Vicari F; Laurent JX
    Med Chir Dig; 1977; 6(7):499-503. PubMed ID: 609305
    [No Abstract]   [Full Text] [Related]  

  • 44. [Trial of a new psychotropical agent in digestive pathology: the fenpentadiol].
    Alary R; Chapuy H; Dietsch R; Savoye B
    J Med Lyon; 1971 Jun; 52(210):951-5. PubMed ID: 5132690
    [No Abstract]   [Full Text] [Related]  

  • 45. [Modirit in digestive pathology].
    Dubarry JJ; Quinton A; Bancons J; Chabellard
    Bord Med; 1970 Sep; 3(9):2205-8. PubMed ID: 4394733
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic clinical trial sedative Edym (capsules). Results obtained in 50 patients].
    Bordas Alsina DJ
    Rev Esp Enferm Apar Dig; 1973 Nov; 41(5):629-36. PubMed ID: 4770561
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases].
    Ryss ES; Fishzon-Ryss IuI
    Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263
    [No Abstract]   [Full Text] [Related]  

  • 48. [Digestive insufficiency and its treatment with a new three-phase enzyme drug].
    Krueger GA
    Landarzt; 1968 Aug; 44(24):1156-61. PubMed ID: 4236296
    [No Abstract]   [Full Text] [Related]  

  • 49. [Study of R.P. 13,907 in current digestive pathology].
    Abry MM
    J Med Lyon; 1968 Jan; 49(135):129-31. PubMed ID: 5647282
    [No Abstract]   [Full Text] [Related]  

  • 50. [Place of tranquilizer therapy in digestive tract pathology: study of oxazepam].
    Hallacq A
    Lyon Med; 1969 Sep; 222(31):251-4. PubMed ID: 5398814
    [No Abstract]   [Full Text] [Related]  

  • 51. [Action of a new neurosedative and antispasmodic drug in digestive pathology].
    Chabanon R; Dietsch R; Savoye B; Chapuy H; Girard M
    J Med Lyon; 1971 Jan; 52(200):63-4. PubMed ID: 4400245
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapeutic experiences with a new preparation against digestive disorders].
    Filser L
    Med Monatsschr; 1973 Apr; 27(4):181-2. PubMed ID: 4709327
    [No Abstract]   [Full Text] [Related]  

  • 53. [Dynamics of some clinical electroencephalographic indices under the effect of anabolic hormones in chronic digestive disorders in young children].
    Minkov IP
    Pediatr Akus Ginekol; 1976; (2):29-30. PubMed ID: 948399
    [No Abstract]   [Full Text] [Related]  

  • 54. [Ornitaine and dibilene in gynecology].
    Paoli A
    Rev Fr Gynecol Obstet; 1966 Nov; 61(11):825-8. PubMed ID: 4167015
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prokinetic medication in gastroenterology].
    Lachter J; Eidelman S
    Harefuah; 1998 Apr; 134(7):553-7. PubMed ID: 10909602
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use in digestive pathology of the association of: a major neuroleptic and an anticholinergic].
    Rubet ; Prost ; Hallacq ; Girard M
    J Med Lyon; 1969 May; 50(165):877-8 passim. PubMed ID: 5399270
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of betaine in reversing alcoholic steatosis.
    Barak AJ; Beckenhauer HC; Badakhsh S; Tuma DJ
    Alcohol Clin Exp Res; 1997 Sep; 21(6):1100-2. PubMed ID: 9309323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapeutic results of the use of lipocaic heparin in diabetic eye disorders].
    Boutier
    J Med Lyon; 1969 Feb; 50(158):229-30. PubMed ID: 4181200
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical study of a new drug with neuro-spasmolytic action in digestive pathology].
    Miniconi P; Perrin D; Nédelec G; Legeais M
    Bord Med; 1971 Nov; 4(11):3329-38. PubMed ID: 5136885
    [No Abstract]   [Full Text] [Related]  

  • 60. [The influence of a new hepato-protective agent and detoxicant on pre-renal, renal and post-renal hyperazotemia].
    Olivieri V
    Minerva Med; 1966 Jan; 57(8):279-88. PubMed ID: 4159839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.